Hongyu Ding
5PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 27, 2024
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in <i>KEAP1</i> mutant lung cancer.Ray Pillai, Sarah E LeBoeuf, Yuan Hao
|Jul 10, 2023
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in <i>KEAP1</i> mutant lung cancer.Ray Pillai, Sarah E LeBoeuf, Yuan Hao
|Nov 17, 2021
Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition.Hongyu Ding, Zihong Chen, Katherine Wu
|Jul 10, 2021
UBQLN4 is an ATM substrate that stabilizes the anti-apoptotic proteins BCL2A1 and BCL2L10 in mesothelioma.Fang Liu, RunSang Pan, HongYu Ding
|Jul 25, 2020
Defining relative mutational difficulty to understand cancer formation.Lin Shan, Jiao Yu, Zhengjin He
Pageof 1
Frequent Collaborators
3 joint publications
Ray Pillai
3 joint publications
Thales Papagiannakopoulos
2 joint publications
Triantafyllia Karakousi
2 joint publications
Volkan I Sayin
2 joint publications
Shih Ming Huang
2 joint publications
Sarah E LeBoeuf
2 joint publications
Sahith Rajalingam
2 joint publications
Connie New
2 joint publications
Ellie Ivanova
2 joint publications
Burcu Karadal-Ferrena
